Baron Davis Enterprises
2
9M
2
0.20
- Areas of investment
Summary
Baron Davis Enterprises appeared to be the VC, which was created in 2012. The company was established in North America in United States. Baron Davis Enterprises seemed to be an CVC arrangement as part of the organization. The leading representative office of defined VC is situated in the Santa Monica.
The fund was created by Baron Davis.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Baron Davis Enterprises, startups are often financed by Knight Enterprise Fund, Harlem Capital Partners, Cross Culture Ventures. The meaningful sponsors for the fund in investment in the same round are Plexo Capital, GV, Comcast Ventures.
We can highlight the next thriving fund investment areas, such as Social Media, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Blavity. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.20
- Investments by industry
- Social Media (1)
- Medical Device (1)
- Health Care (1)
- Pharmaceutical (1)
- Biotechnology (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 325M
- Group Appearance index
- 1.00
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| H1 | 22 Mar 2020 | Biotechnology, Health Care, Medical Device, Pharmaceutical | Early Stage Venture | 12M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.